MedTech News
.................... by Andrew Celentano
Lab-Grown Brains Could One Day Help Reawaken Nerve Regeneration
Lab-grown brains could help scientists reawaken nerve regeneration.
GE HealthCare earns FDA nod for AI-enabled radiotherapy tech
GE HealthCare (Nasdaq:GEHC) announced today that it received FDA 510(k) clearance for its MIM Contour ProtégéAI+ 2.0 software.
University of Glasgow Develops Wireless Implantable Device to Advance Bladder Cancer Therapy
The device, created by engineers and cancer scientists led by Professor David Flynn, represents an important step toward next-generation implantable photonic medical technologies
Immunotherapy added to radiation therapy boosts survival in localized prostate cancer
Results of a multicenter clinical trial found that adding the investigational adenoviral-based viral immunotherapy aglatimagene besadenovec (alglatimagene, CAN-2409) to standard radiation therapy improved disease-free survival for patients with intermediate- or high-risk localized prostate cancer.
AI tool simplifies and scales complete genome assembly, supporting advances in diagnostics and precision medicine
An international research team led by the A*STAR Genome Institute of Singapore (A*STAR GIS) has developed HERRO, an artificial intelligence (AI) tool that could make it easier and more cost-effective to produce complete, high-quality genome assemblies.
A 3D printed stent, shaped like a lily, could speed recovery after weight-loss surgery
Now, researchers at New York University say they have developed a new stent for surgery recovery. Their findings have been published in Advanced Healthcare Materials.
Conductive plastic mimics heart cell ion signaling for first time
The findings, published in Nature Communications, pave the way for new types of prostheses, heart implants and sensors in the long term.
Engineered Salmonella deliver cancer-killing viruses, shrinking liver and pancreatic tumors in mice
Researchers at the University of Massachusetts Amherst have designed non-toxic Salmonella bacteria to deliver viruses that are safe to humans but potent against liver and pancreatic cancer tumors—two cancers with an extremely poor prognosis.